학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 181건 | 목록 1~10
Academic Journal
Engert, ABalduini, CBrand, ACoiffier, BCordonnier, CDohner, Hde Wit, TDEichinger, SFibbe, WGreen, Tde Haas, FIolascon, AJaffredo, TRodeghiero, FSalles, GSchuringa, JJAndre, MAndre-Schmutz, IBacigalupo, ABochud, PYden Boer, MBonini, CCamaschella, CCant, ACappellini, MDCazzola, MLo Celso, CDimopoulos, MDouay, LDzierzak, EEinsele, HFerreri, ADe Franceschi, LGaulard, PGottgens, BGreinacher, AGresele, PGribben, Jde Haan, GHansen, JBHochhaus, AKadir, RKaveri, SKouskoff, VKuhne, TKyrle, PLjungman, PMaschmeyer, GMendez-Ferrer, SMilsom, MMummery, COssenkoppele, GPecci, APeyvandi, FPhilipsen, SReitsma, PRibera, JMRisitano, ARivella, SRuf, WSchroeder, TScully, MSocie, GStaal, FStanworth, SStauder, RStilgenbauer, STamary, HTheilgaard-Monch, KThein, SLTilly, HTrneny, MVainchenker, WVannucchi, AMViscoli, CVrielink, HZaaijer, HZanella, AZolla, LZwaginga, JJMartinez, PAvan den Akker, EAllard, SAnagnou, NAndolfo, IAndrau, JCAngelucci, EAnstee, DAurer, IAvet-Loiseau, HAydinok, YBakchoul, TBalduini, ABarcellini, WBaruch, DBaruchel, ABayry, JBento, Cvan den Berg, ABernardi, RBianchi, PBigas, ABiondi, ABohonek, MBonnet, DBorchmann, PBorregaard, NBraekkan, Svan den Brink, MBrodin, EBullinger, LBuske, CButzeck, BCammenga, JCampo, ECarbone, ACervantes, FCesaro, SCharbord, PClaas, FCohen, HConard, JCoppo, PCorrons, JLVda Costa, LDavi, FDelwel, RDianzani, IDomanovic, DDonnelly, PDrnovsek, TDDreyling, MDu, MQDufour, CDurand, CEfremov, DEleftheriou, AElion, JEmonts, MEngelhardt, MEzine, SFalkenburg, FFavier, RFederico, MFenaux, PFitzgibbon, JFlygare, JFoa, RForrester, LGalacteros, FGaragiola, IGardiner, CGarraud, Ovan Geet, CGeiger, HGeissler, JGerming, UGhevaert, CGirelli, DGodeau, BGokbuget, NGoldschmidt, HGoodeve, AGraf, TGraziadei, GGriesshammer, MGruel, YGuilhot, Fvon Gunten, SGyssens, IHalter, JHarrison, CHarteveld, CHellstrom-Lindberg, EHermine, OHiggs, DHillmen, PHirsch, HHoskin, PHuls, GInati, AJohnson, PKattamis, AKiefel, VKleanthous, MKlump, HKrause, DHovinga, JKLacaud, GLacroix-Desmazes, SLandman-Parker, JLeGouill, SLenz, Gvon Lilienfeld-Toal, Mvon Lindern, MLopez-Guillermo, ALopriore, ELozano, MMacIntyre, EMakris, MMartens, JMathas, SMatzdorff, AMedvinsky, AMenendez, PMigliaccio, ARMiharada, KMikulska, MMinard, VMontalban, Cde Montalembert, MMontserrat, EMorange, PEMountford, JMuckenthaler, MMuller-Tidow, CMumford, ANadel, BNavarro, JTel Nemer, WNoizat-Pirenne, FO'Mahony, BOldenburg, JOlsson, MOostendorp, RPalumbo, APassamonti, FPatient, Rde Latour, RPPflumio, FPierelli, LPiga, APollard, DRaaijmakers, MRadford, JRambach, RRao, AKRaslova, HRebulla, PRees, DRibrag, VRijneveld, ARinalducci, SRobak, TRoberts, IRodrigues, CRosendaal, FRosenwald, ARule, SRusso, RSaglio, GSanchez, MScharf, RESchlenke, PSemple, JSierra, JSo-Osman, CSoria, JMStamatopoulos, KStegmayr, BStunnenberg, HSwinkels, DBarata, JPTTaghon, TTaher, ATerpos, EThachil, JTissot, JDTouw, IToye, ATrappe, RTraverse-Glehen, AUnal, SVaulont, SViprakasit, VVitolo, Uvan Wijk, RWojtowicz, AZeerleder, SZieger, B
Haematologica. 101(2):115-208
Academic Journal
Kwon MC; Discovery Oncology, Janssen R&D, Beerse, Belgium.; Thuring JW; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium.; Querolle O; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium.; Dai X; Discovery Product Development and Supply, Janssen R&D, Shanghai, China.; Verhulst T; Discovery Oncology, Janssen R&D, Beerse, Belgium.; Pande V; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium.; Marien A; Discovery Oncology, Janssen R&D, Beerse, Belgium.; Goffin D; Discovery Oncology, Janssen R&D, Beerse, Belgium.; Wenge DV; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, and Harvard Medical School, Boston, MA.; Yue H; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.; Cutler JA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, and Harvard Medical School, Boston, MA.; Jin C; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.; Perner F; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, and Harvard Medical School, Boston, MA.; Hogeling SM; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Shaffer PL; Discovery Product Development and Supply, Janssen R&D, Spring House, PA.; Jacobs F; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium.; Vinken P; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium.; Cai W; Discovery Product Development and Supply, Janssen R&D, Shanghai, China.; Keersmaekers V; Discovery Oncology, Janssen R&D, Beerse, Belgium.; Eyassu F; Discovery Oncology, Janssen R&D, Beerse, Belgium.; Bhogal B; Discovery Product Development and Supply, Janssen R&D, Spring House, PA.; Verstraeten K; Discovery Oncology, Janssen R&D, Beerse, Belgium.; El Ashkar S; Discovery Oncology, Janssen R&D, Beerse, Belgium.; Perry JA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, and Harvard Medical School, Boston, MA.; Jayaguru P; Translational Research, Janssen R&D, Spring House, PA.; Barreyro L; Translational Research, Janssen R&D, Spring House, PA.; Kuchnio A; Discovery Oncology, Janssen R&D, Beerse, Belgium.; Darville N; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium.; Krosky D; Discovery Product Development and Supply, Janssen R&D, Spring House, PA.; Urbanietz G; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium.; Verbist B; TMEDS, Janssen R&D, Beerse, Belgium.; Edwards JP; Discovery Product Development and Supply, Janssen R&D, Spring House, PA.; Cowley GS; Discovery Product Development and Supply, Janssen R&D, Spring House, PA.; Kirkpatrick R; Discovery Product Development and Supply, Janssen R&D, Spring House, PA.; Steele R; Discovery Product Development and Supply, Janssen R&D, Spring House, PA.; Ferrante L; Early Development, Janssen R&D, Spring House, PA.; Guttke C; Translational Research, Janssen R&D, Spring House, PA.; Daskalakis N; Early Development, Janssen R&D, Spring House, PA.; Pietsch EC; Discovery Oncology, Janssen R&D, Spring House, PA.; Wilson DM; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium.; Attar R; Translational Research, Janssen R&D, Spring House, PA.; Elsayed Y; Discovery Oncology, Janssen R&D, Spring House, PA.; Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.; Schuringa JJ; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Armstrong SA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, and Harvard Medical School, Boston, MA.; Packman K; Early Development, Janssen R&D, Cambridge, MA.; Philippar U; Discovery Oncology, Janssen R&D, Beerse, Belgium.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Academic Journal
Dembitz V; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Department of Physiology and Croatian Institute for Brain Research, University of Zagreb School of Medicine, Zagreb, Croatia.; Lawson H; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; The Institute of Cancer Research, London, UK.; Burt R; Division of Cell and Molecular Biology, Imperial College London, London, UK.; Francis Crick Institute, London, UK.; Natani S; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Philippe C; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; INSERM U1242, University of Rennes, Rennes, France.; James SC; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Atkinson S; Division of Cell and Molecular Biology, Imperial College London, London, UK.; Francis Crick Institute, London, UK.; Durko J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Wang LM; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; The Institute of Cancer Research, London, UK.; Campos J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; The Institute of Cancer Research, London, UK.; Magee AMS; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Woodley K; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Austin MJ; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Rio-Machin A; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Experimental Hematology Lab, IIS-Fundación Jimenez Díaz, UAM, Madrid, Spain.; Casado P; Centre for Cancer Genomics & Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Bewicke-Copley F; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Centre for Cancer Genomics & Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Rodriguez Blanco G; The University of Edinburgh MRC Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.; Pereira-Martins D; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Oudejans L; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Boet E; Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm U1037, CNRS U5077, LabEx Toucan, Toulouse, France.; Équipe labellisée Ligue Nationale Contre le Cancer 2023, Toulouse, France.; von Kriegsheim A; The University of Edinburgh MRC Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.; Schwaller J; University Children's Hospital and Department of Biomedicine (DBM), University of Basel, Basel, Switzerland.; Finch AJ; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Patel B; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Sarry JE; Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm U1037, CNRS U5077, LabEx Toucan, Toulouse, France.; Équipe labellisée Ligue Nationale Contre le Cancer 2023, Toulouse, France.; Tamburini J; Translational Research Centre in Onco-hematology, Faculty of Medicine, University of Geneva and Swiss Cancer Center Leman, Geneva, Switzerland.; Schuringa JJ; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Hazlehurst L; Modulation Therapeutics, Morgantown, WV, USA.; Copland Iii JA; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA.; Yuneva M; Francis Crick Institute, London, UK.; Peck B; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Cutillas P; Centre for Cancer Genomics & Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Fitzgibbon J; Centre for Cancer Genomics & Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Rouault-Pierre K; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Kranc K; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; The Institute of Cancer Research, London, UK.; Gallipoli P; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. p.gallipoli@qmul.ac.uk.
Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Academic Journal
Lima K; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil. Electronic address: kelilima@usp.br.; Nogueira FL; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.; Cipelli M; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.; Carvalho MFL; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.; Pereira-Martins DA; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil; Department of Experimental Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.; da Silva WF; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.; Cavaglieri RC; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.; Nardinelli L; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.; Leal AM; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.; Velloso EDRP; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.; Bendit I; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.; Câmara NOS; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.; Schuringa JJ; Department of Experimental Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.; Machado-Neto JA; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil. Electronic address: jamachadoneto@usp.br.; Rego EM; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil. Electronic address: eduardo.rego@fm.usp.br.
Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0712 (Electronic) Linking ISSN: 00142999 NLM ISO Abbreviation: Eur J Pharmacol Subsets: MEDLINE
Academic Journal
Groenen AG; Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Halmos B; Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; van Zeventer IA; Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Salzbrunn JB; Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Mayer ML; Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; La Rose ND; Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Nolte IM; Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Schuringa JJ; Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Huls G; Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Westerterp M; Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: m.westerterp@umcg.nl.
Publisher: Elsevier Country of Publication: Ireland NLM ID: 0242543 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1484 (Electronic) Linking ISSN: 00219150 NLM ISO Abbreviation: Atherosclerosis Subsets: MEDLINE
Editorial & Opinion
Salustiano-Bandeira ML; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.; Moreira-Aguiar A; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.; Pereira-Martins DA; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.; Coelho-Silva JL; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.; Weinhäuser I; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.; França-Neto PL; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.; Lima AS; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.; Lima AS; Department of Medical Imaging, Hematology, and Oncology, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil.; Baccarin AR; Department of Medical Imaging, Hematology, and Oncology, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil.; Silva FB; Department of Medical Imaging, Hematology, and Oncology, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil.; de Melo MA; Department of Medical Imaging, Hematology, and Oncology, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil.; Niemann FS; Hematology and Transfusion Medicine Center, University of Campinas, Campinas, Brazil.; Nardinelli L; Hematology Division, Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil.; Ortiz Rojas CA; Hematology Division, Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil.; Duarte BK; Hematology and Transfusion Medicine Center, University of Campinas, Campinas, Brazil.; Department of Internal Medicine, University of Campinas, Campinas, Brazil.; Araujo AS; Department of Internal Medicine, Hematology and Hemotherapy Foundation of Pernambuco, Recife, Brazil.; Azevedo EA; Department of Virology, Fundação Oswaldo Cruz, Instituto de Pesquisas Aggeu Magalhães, Recife, Brazil.; Morais CN; Department of Virology, Fundação Oswaldo Cruz, Instituto de Pesquisas Aggeu Magalhães, Recife, Brazil.; Figueiredo-Pontes LL; Department of Medical Imaging, Hematology, and Oncology, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil.; Schuringa JJ; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.; Huls G; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.; Bendit I; Hematology Division, Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil.; Rego EM; Hematology Division, Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil.; Olalla Saad ST; Hematology and Transfusion Medicine Center, University of Campinas, Campinas, Brazil.; Department of Internal Medicine, University of Campinas, Campinas, Brazil.; Traina F; Department of Medical Imaging, Hematology, and Oncology, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil.; Bezerra MA; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.; Lucena-Araujo AR; Department of Genetics, Federal University of Pernambuco, Recife, Brazil. antonio.araujo@ufpe.br.
Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Schuringa, JJ
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어